Published in Lancet on August 13, 1994
Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab (2009) 1.17
Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma (2014) 0.86
Diagnosing growth hormone deficiency in adults. Int J Endocrinol (2012) 0.79
Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease. Clin Proteomics (2016) 0.75
Diagnosing growth-hormone deficiency in adults. Lancet (1994) 1.73
Diagnosis of growth hormone deficiency in adults. Lancet (1994) 1.08
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation (1999) 8.17
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (1999) 7.14
Diagnosis of growth-hormone deficiency in adults. Lancet (1994) 5.93
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology (2006) 3.59
Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med (1994) 2.74
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int (2009) 2.63
Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int (1998) 2.11
Screening for osteoporosis: what is the role of heel ultrasound? Med J Aust (1996) 2.01
Distribution of two distinct Ca2+-ATPase-like proteins and their relationships to the agonist-sensitive calcium store in adrenal chromaffin cells. Nature (1989) 1.81
Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int (2000) 1.77
Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int (2008) 1.68
Mechanism of Ca2+ wave propagation in pancreatic acinar cells. J Biol Chem (1992) 1.66
Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation (2001) 1.65
Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem (1998) 1.59
Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun (1988) 1.58
Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J Biol Chem (2000) 1.54
Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation (2000) 1.54
Linking family hardship to children's lives. Child Dev (1985) 1.52
Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem (2000) 1.51
Accuracy of on-line databases in determining vital status. J Clin Epidemiol (2001) 1.47
Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patients. Cancer J (2001) 1.46
Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) Circulation (1998) 1.45
The validity of posttraumatic stress disorder among Vietnamese refugees. J Trauma Stress (1997) 1.42
Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. Eur J Endocrinol (1997) 1.42
A major role for protein kinase C in calcium-activated exocytosis in permeabilised adrenal chromaffin cells. FEBS Lett (1988) 1.42
Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ (1995) 1.41
Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab (1991) 1.40
Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials. Catheter Cardiovasc Interv (2000) 1.39
Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus. J Virol (2005) 1.38
Growth hormone deficiency in adults: to treat or not to treat. Aust N Z J Med (1999) 1.38
Non-operative diagnosis of renal sinus lipomatosis simulating tumour of the renal pelvis. Br J Urol (1988) 1.37
The IGF axis and programmed cell death. Immunol Cell Biol (1999) 1.33
Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem (1986) 1.31
Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor. J Biol Chem (2000) 1.30
Amantadine dosage in treatment of Parkinson's disease. Lancet (1970) 1.30
Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab (1991) 1.29
Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. J Clin Invest (1986) 1.28
Effects of long term octreotide on gall stone formation and gall bladder function. BMJ (1992) 1.27
Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J Virol (2006) 1.27
Simultaneous measurements of cytosolic calcium and secretion in single bovine adrenal chromaffin cells by fluorescent imaging of fura-2 in cocultured cells. J Cell Biol (1989) 1.27
Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab (1999) 1.25
Spatial localization of the stimulus-induced rise in cytosolic Ca2+ in bovine adrenal chromaffin cells. Distinct nicotinic and muscarinic patterns. FEBS Lett (1989) 1.25
Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents. J Magn Reson Imaging (2001) 1.24
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24
Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int (1995) 1.24
Somatogenic receptors of rat liver: regulation by insulin. Endocrinology (1980) 1.23
Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int (2007) 1.22
Utility of patient-activated cardiac event recorders in general clinical practice. Am J Cardiol (1997) 1.22
Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem (1982) 1.22
Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab (2000) 1.21
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) (1997) 1.19
Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J Bone Miner Res (2000) 1.18
Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis (1986) 1.18
The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res (1995) 1.18
Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol (1988) 1.17
The control of cytoskeletal actin and exocytosis in intact and permeabilized adrenal chromaffin cells: role of calcium and protein kinase C. Cell Signal (1989) 1.17
In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. Circulation (1995) 1.16
A rapid procedure for detecting recombinant plasmids using butanol extraction. Biotechniques (1991) 1.15
Validation of in vivo myocardial strain measurement by magnetic resonance tagging with sonomicrometry. J Am Coll Cardiol (2001) 1.14
Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab (2000) 1.13
Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology (1991) 1.13
Risk factors for low birth weight in a socio-economically disadvantaged population: parity, marital status, ethnicity and cigarette smoking. Eur J Epidemiol (2003) 1.13
Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology (1994) 1.12
Cross-sectional study of sexual behaviour and knowledge about HIV among urban, rural, and minority residents in Viet Nam. Bull World Health Organ (2003) 1.11
Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol (2000) 1.11
Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. Psychosom Med (1992) 1.10
Isolation of photosynthetic catalysts from cyanobacteria. Biochim Biophys Acta (1979) 1.10
Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a "real" difference? Psychosom Med (1992) 1.09
IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments. Oncogene (2012) 1.07
Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell Signal (2006) 1.07
Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol (1997) 1.07
Induction of exocytosis from permeabilized mast cells by the guanosine triphosphatases Rac and Cdc42. Mol Biol Cell (1998) 1.07
The caffeine-sensitive Ca2+ store in bovine adrenal chromaffin cells; an examination of its role in triggering secretion and Ca2+ homeostasis. FEBS Lett (1990) 1.06
Quality of life in osteoporosis: reliability, consistency, and validity of the Osteoporosis Assessment Questionnaire. J Rheumatol (1998) 1.06
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Vitamin D status and parathyroid hormone in a urban population in Vietnam. Osteoporos Int (2010) 1.05
Binding proteins for insulin-like growth factors in adult rat serum. Comparison with other human and rat binding proteins. Biochem Biophys Res Commun (1987) 1.05
A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab (2000) 1.04
Femoral neck axis length, height loss and risk of hip fracture in males and females. Osteoporos Int (1998) 1.04
Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. J Biol Chem (1998) 1.03
A twin study of polycystic ovary syndrome. Fertil Steril (1995) 1.03
Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation (1994) 1.02
Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects. J Hum Hypertens (2000) 1.02
Identification of undiagnosed type 2 diabetes by systolic blood pressure and waist-to-hip ratio. Diabetologia (2010) 1.02
Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J Biol Chem (1998) 1.02
Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. J Endocrinol (2000) 1.02
Rho guanine nucleotide dissociation inhibitor protein (RhoGDI) inhibits exocytosis in mast cells. EMBO J (1996) 1.01
Bleomycin-induced flagellate dermatitis: a clinical and histopathological review. Br J Dermatol (1994) 1.01
Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc Natl Acad Sci U S A (1991) 1.01
Ecological effects of sewage discharge in the marine environment. Proc R Soc Lond B Biol Sci (1971) 1.01
The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest (1998) 1.01
Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J Clin Endocrinol Metab (1987) 1.01